DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...

The key vendors in the global Insulin Pump market are Cellenovo, Sooil Development, Valeritas, Inc, JingasuDelfu Co., Ltd., ...

In an open-loop system, the user manually controls insulin delivery ... diabetes technology companies are looking to replicate. Tandem Diabetes Care and Medtronic are both designing patch pumps. Last ...

New Zealand Society for the Study of Diabetes (NZSSD) welcomes Pharmac’s decision to fund continuous glucose monitors and insulin pumps, which allow automated insulin delivery, for people with type 1 ...

Pharmac – Te Pātaka Whaioranga has decided to fund continuous glucose monitors (CGMs), insulin pumps, and insulin pump consumables for people with type 1 diabetes from 1 October 2024.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

A series of case reports to be presented at this year’s Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept), describe how a technology giving insulin doses ...

New over-the-counter sensors, an Abbott-Medtronic partnership and Roche’s first CGM are among diabetes technology’s top stories so far in 2024. Check out MedTech Dive’s roundup of the latest news.

Medtronic plc (NYSE: MDT) is a leading global medical device maker in the medical sector. Its innovative and critical medical ...

Medtronic plc (NYSE:MDT) is one of the largest medical device companies. It develops and manufactures therapeutic medical ...

Carillon Eagle Growth & Income Fund highlighted stocks like Medtronic plc (NYSE:MDT), in the second quarter 2024 investor letter. Medtronic plc (NYSE:MDT) develops, manufactures, and distributes ...

Diabetes is Medtronic's smallest segment by revenue, but it has been growing faster than the rest of its business for a while. The recent boost is partly due to Medtronic's newest insulin pump ...